Drug Type siRNA |
Synonyms- |
Target |
Action inhibitors |
Mechanism lipoprotein(a) inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Lipoprotein (a) hyperlipoproteinemia | IND Approval | China | 17 Dec 2025 | |
| Lipoprotein (a) hyperlipoproteinemia | IND Approval | China | 17 Dec 2025 | |
| Atherosclerosis | Preclinical | China | 15 Mar 2025 |





